As a result of our algorithm, we identified a signature of 5 CTC-specific genes, i.e., ADPRHL1, ELF3, FCF1, TFF1 and TFF3, and explored its clinical significance according to their expression in CTC-enriched blood samples in our breast cancer case series. This evidence concerns the gene ADPRHL1 and breast carcinoma.